TSBX - Turnstone Biologics Corp
0.355
0.005 1.408%
Share volume: 283,774
Last Updated: 08-08-2025
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
-0.03%
PREVIOUS CLOSE
CHG
CHG%
$0.35
0.01
0.01%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 03-31-2025 | |
|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q1 2025 | |
| Report Date | 05-13-2024 | 08-14-2024 | 11-12-2024 | 05-08-2025 | |
| Cash flow financing | 0.000 | -48.000 K | 59.000 K | 0.000 | |
| Other financing cash flows | 0.000 | 44.000 K | 0.000 | 0.000 | |
| Cash flow | -17.460 M | 2.968 M | 6.732 M | -7.079 M | |
| Net income | -19.629 M | -21.304 M | -17.032 M | -11.806 M | |
| Depreciation | 509.000 K | 498.000 K | 491.000 K | 301.000 K | |
| Changes in inventories | 0.000 | 0.000 | 0.000 | 0.000 | |
| Changes in receivables | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Cashflow | 14.095 M | 18.941 M | 24.250 M | 12.000 K | |
| Net Borrowings | -84.865 M | 0.000 | 0.000 | 0.000 | |
| Investing Activity Other | 0.000 | 0.000 | 0.000 | 0.000 | |
| Dividends Paid | 0.000 | 0.000 | 0.000 | 0.000 | |
| Exchange Rate Effect | 0.000 | 0.000 | 0.000 | 0.000 | |
| Capital Expenditures | -144.000 K | 80.000 K | -1.000 K | -12.000 K | |
| Cash Change | 77.847 M | 2.968 M | 6.732 M | -7.079 M |